Good oral health is a basic human right and every person on the planet deserves access to products that prevent disease. The World Health Organization has identified oral health as a key priority, setting a global strategy for universal health coverage by 2030. Globally, oral diseases impact over 3.5 billion people and cost global economies in excess of US$500 billion per annum, placing added pressure on ever-increasing healthcare budgets.
Eikonic has successfully completed a proof of concept, pre-clinical studies and with patent registrations in major jurisdictions is now in the process of completing research and development; and commercialising our gold-infused platform technology in order to address this critical challenge. The oral healthcare market is estimated to be worth US$40b and Eikonic aims to tackle those directly affected by oral disease as well as reducing the more than 1.4 billion people affected by chronic diseases associated with poor oral health.
Investment sought: $10 - $40 million
More Project details will be updated soon.
Request more information
Please fill in the form below. Mandatory fields are marked with
"*" indicates required fields